Andre Jacques Auberton Herve - Jul 15, 2021 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director
Signature
/s/ Andre-Jacques Auberton-Herve
Stock symbol
BNKL
Transactions as of
Jul 15, 2021
Transactions value $
$210,201
Form type
4
Date filed
6/21/2022, 05:49 PM
Next filing
Jul 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Options Exercise $187K +51.9K +23.11% $3.60* 276K Jul 15, 2021 Shares held through Star SCI or 4A Consulting and Engineering F1
transaction BNKL Common Stock, par value $0.001 per share Options Exercise $23.7K +7.5K +2.71% $3.16* 284K Jul 15, 2021 Shares held through Star SCI or 4A Consulting and Engineering F1
holding BNKL Common Stock, par value $0.001 per share 95.1K Jul 15, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNKL Stock Option (right to buy) Options Exercise $0 -51.9K -44.82% $0.00 63.9K Jul 15, 2021 Common Stock, par value $0.001 per share 51.9K $3.60 Direct F1
transaction BNKL Stock Option (right to buy) Options Exercise $0 -7.5K -100% $0.00* 0 Jul 15, 2021 Common Stock, par value $0.001 per share 7.5K $3.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Payment of exercise price was satisfied through the satisfaction of an Issuer promissory note held by the reporting person.
F2 The options vest 2,500 on May 31, 2019, 2,500 on November 30, 2019 and 2,500 on May 31, 2020.